Catalyst Funds Management’s MacroGenics MGNX Stock Holding History

Catalyst Funds Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,700	Closed	-$51.2K	–	796
2026 Q1	$51.2K	Buy	+17,700	New	+$37.8K	0.01%	540
2025 Q4	–	Sell	-54,600	Closed	-$91.7K	–	483
2025 Q3	$91.7K	Buy	54,600 +26,100	+92%	+$42.2K	0.01%	461
2025 Q2	$34.5K	Buy	+28,500	New	+$41.3K	0.01%	397

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Catalyst Funds Management's MGNX Position: Q2 2026 in Review

Catalyst Funds Management sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 17,700 shares — an estimated $51.2K sold.

Catalyst Funds Management first reported a position in MGNX in Q2 2025 and held it in 3 quarters. The position peaked at $91.7K in Q3 2025. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Catalyst Funds Management reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
Catalyst Funds Management sold 17,700 MacroGenics shares in Q2 2026, an estimated $51.2K.
Catalyst Funds Management first reported a position in MacroGenics in Q2 2025 and held it in 3 quarters.
Catalyst Funds Management's MacroGenics position peaked at $91.7K in Q3 2025.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.